Human Immunodeficiency Virus  >>  stavudine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

23 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
stavudine / Generic mfg.
D4T, NCT02670772: Dose Optimisation of Stavudine for the Treatment of HIV Infection

Completed
3b
1077
RoW
Stavudine, d4t, Tenofovir Disoproxil Fumarate, TDF
Willem Daniel Francois Venter, Bill and Melinda Gates Foundation
Acquired Immune Deficiency Syndrome, Human Immunodeficiency Virus
12/14
12/15
NCT00002246: A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex

Completed
3
20
US, Europe, RoW
Stavudine
Bristol-Myers Squibb
AIDS Dementia Complex, HIV Infections
03/99
03/99
NCT00002224: Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

Completed
3
120
US, Canada
Nelfinavir mesylate, Stavudine, Didanosine
Bristol-Myers Squibb
HIV Infections
03/99
03/99
NCT00002429: Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Completed
3
500
US, Canada
Lamivudine/Zidovudine, Nelfinavir mesylate, Stavudine, Didanosine
Bristol-Myers Squibb
HIV Infections
01/01
01/01
NCT00158821: Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

Completed
3
180
US
Viread (tenofovir disoproxil fumarate), Viread, Sustiva (Efavirenz), Sustiva, Epivir (Lamivudine), Epivir, Zerit (Stavudine) Placebo, Zerit
Gilead Sciences
HIV Infections
12/01
06/13
NCT00005918: Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients

Completed
3
730
US, Canada, Europe, RoW
Efavirenz, Lamivudine, Stavudine
Bristol-Myers Squibb
HIV Infections
04/02
04/02
NCT00116298: Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)

Completed
3
900
US, Canada, Europe, RoW
stavudine, efavirenz, lamivudine
Bristol-Myers Squibb
HIV Infections, AIDS
01/05
01/05
NCT00002109: Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy

Completed
3
US
Thymopentin, Stavudine, Zidovudine, Zalcitabine, Didanosine
Immunobiology Research Institute
HIV Infections
 
 
NCT00002230: A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients

Completed
3
100
US
Hydroxyurea, Efavirenz, Stavudine, Didanosine
Northwestern University
HIV Infections
 
 
NCT00002374: A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients

Completed
3
120
US
Ritonavir, Nelfinavir mesylate, Saquinavir, Stavudine
Hoffmann-La Roche
HIV Infections
 
 
NCT00002362: A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Suspended
3
US
Abacavir sulfate, Efavirenz, Emtricitabine, Stavudine
Triangle Pharmaceuticals
HIV Infections
 
 
NCT00006208: A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Unknown status
3
Canada, US, RoW
Efavirenz, Emtricitabine, Stavudine, Didanosine
Triangle Pharmaceuticals
HIV Infections
 
 
NCT00006397: Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

Unknown status
3
200
US
Indinavir sulfate, Ritonavir, Stavudine, Didanosine
PPD
HIV Infections
 
 
NCT00135369: Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen

Completed
3
300
US
stavudine extended-release, lamivudine, efavirenz
Bristol-Myers Squibb
HIV Infections
07/05
07/05
NCT00050895: Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Completed
3
775
US, RoW
Lopinavir/ritonavir, Efavirenz, Stavudine, Zidovudine, Lamivudine, Tenofovir disoproxil fumarate
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
 
03/06
NCT00528957 / 2007-003418-32: Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

Completed
3
97
US, Europe, RoW
Tenofovir DF, Viread®, Zidovudine, Stavudine
Gilead Sciences
HIV Infections
04/09
08/17
NCT00006154: A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Completed
3
165
Canada
Indinavir sulfate, IDV, Ritonavir, RTV, Abacavir sulfate, ABC, Efavirenz, DMP, Stavudine, d4T, Didanosine, ddI, Aldesleukin, Proleukin, IL-2
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
 
 
NCT00074581: Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Completed
3
3526
US, RoW
Atazanavir, Reyataz, Didanosine, Videx, Efavirenz, Sustiva, Emtricitabine/Tenofovir disoproxil fumarate, Truvada, Lamivudine, Epivir, 3TC, Lopinavir/Ritonavir, Kaletra, Nevirapine, Viramune, NVP, Stavudine, Zerit, d4T, Tenofovir disoproxil fumarate, Viread, TDF, Zidovudine/Lamivudine, Combivir
National Institute of Allergy and Infectious Diseases (NIAID), HIV Prevention Trials Network
HIV Infections
05/15
05/15
2012-004556-11: Study of monotherapy versus standard care in patients affected by HIV. Studio di monoterapia rispetto allo standard di cura in pazienti con HIV.

Completed
3
375
Europe
Capsule, soft, Coated tablet, Tablet, Film-coated tablet, Capsule, hard, NORVIR*FL 84CPS MOLLI 100MG, PREZISTA*60CPR RIV 400MG, KALETRA*120CPR RIV 200MG+50MG, TRUVADA*30CPR RIV 200MG/245MG, ATRIPLA*30CPR RIV600+200+245MG, SUSTIVA*FL 30CPR RIV 600MG, REYATAZ*1FL 30CPS 300MG, KALETRA*360CPR RIV 200MG+50MG, TELZIR*1FL 60CPR RIV 700MG, KIVEXA*BL 30CPR RIV 600MG+300M, COMBIVIR*60CPR RIV 150MG+300MG, PREZISTA*120CPR RIV 300MG, ISENTRESS*FL 180CPR RIV 400MG, EMTRIVA*1FL 30CPS 200MG, EPIVIR*BLIST 30CPR RIV 300MG, VIDEX*30CPS GASTR 400MG, VIREAD*30CPR 245MG, ZERIT*56CPS 40MG, ZIAGEN*6BLISTER 10CPR 300MG, INTELENCE*FL 120CPR 100MG, VIRAMUNE*FL 30CPR 400MG R.P., APTIVUS*FL 120CPS MOLLI 250MG, CELSENTRI*180CPR RIV 300MG
OSPEDALE S. RAFFAELE DI MILANO, Ministero della Salute bando Rf-2009-1526102
HIV infection infezione da HIV, chronic HIV infection infezione da HIV cronica, Diseases [C] - Virus Diseases [C02]
 
 
2004-001827-39: NATIONAL, MULTICENTER, RANDOMISED, OPEN STUDY TO VALUATE THE EFFICACY OF DIFFERENT THERAPEUTIC STRATEGIES TO AVOID THE IMMUNOLOGIC FAILURE IN MULTIRESISTENT HIV-1 INFECTED PATIENTS.

 
3
Europe
NA, NA, VIRAMUNE*60 CPR 200 MG, SUSTIVA*90 CPS 200 MG, VIREAD*30 CPR 245 MG, TRIZIVIR*60 CPR RIV. BLISTER, COMBIVIR*60CPR BL 150/300MG, EPIVIR*60 CPR 150 MG, ZERIT 40*56 CPS 40 MG, ZIAGEN*60 CPR RIV. 300 MG, HIVID 0,750*100 CPR 0,750 MG, RETROVIR* 28 CPR 300 MG, KALETRA*90 CPS X 2 FLACONI, VIDEX 100*60 CPR 100 MG, CRIXIVAN*180 CPS 400 MG, INVIRASE*270 CPS 200 MG, VIRACEPT*270 CPR 250 MG, NORVIR*336 CPS MOLLI 100 MG, AGENERASE*240 CPS 150 MG, FORTOVASE*180 CPS 200 MG, VIRAMUNE*60 CPR 200 MG, SUSTIVA*90 CPS 200 MG, VIREAD*30 CPR 245 MG, TRIZIVIR*60 CPR RIV. BLISTER, COMBIVIR*60CPR BL 150/300MG, EPIVIR*60 CPR 150 MG, ZERIT 40*56 CPS 40 MG, ZIAGEN*60 CPR RIV. 300 MG, HIVID 0,750*100 CPR 0,750 MG, RETROVIR* 28 CPR 300 MG, KALETRA*90 CPS X 2 FLACONI, VIDEX 100*60 CPR 100 MG, CRIXIVAN*180 CPS 400 MG, INVIRASE*270 CPS 200 MG, VIRACEPT*270 CPR 250 MG, NORVIR*336 CPS MOLLI 100 MG, AGENERASE*240 CPS 150 MG, FORTOVASE*180 CPS 200 MG
OSPEDALE S. RAFFAELE
HIV TREATMENT
 
 
2009-010189-48: Randomised trial comparing the introduction of an immediate or deferred new HAART regimen in failing HIV infected patients: the role of lamivudine monotherapy

Completed
3
280
Europe
EPIVIR, ATRIPLA, COMBIVIR, EMTRIVA, KIVEXA, RETROVIR, TRUVADA, VIDEX, VIREAD, ZERIT, ZIAGEN, SUSTIVA, VIRAMUNE, APTIVUS, INVIRASE, KALETRA, PREZISTA, REYATAZ, NORVIR, TELZIR, FUZEON, ISENTRESS, CELSENTRI, EPIVIR, ATRIPLA, COMBIVIR, EMTRIVA, KIVEXA, RETROVIR, TRUVADA, VIDEX, VIREAD, ZERIT, ZIAGEN, SUSTIVA, VIRAMUNE, APTIVUS, INVIRASE, KALETRA, PREZISTA, REYATAZ, NORVIR, TELZIR, FUZEON, ISENTRESS, CELSENTRI
OSPEDALE S. RAFFAELE
HIV infected patients
 
 
2008-007765-23: MoLO study - Evaluation of cost/efficacy ratio of monotherapy with lopinavir/ritonavir versus standard in patients treated with protesi inhibotors in virologic suppressison.

 
3
240
Europe
KALETRA, PREZISTA, TRUVADA, KIVEXA, COMBIVIR, REYATAZ, VIRAMUNE, ZIAGEN, ZERIT, EMTRIVA, EPIVIR, VIREAD, RETROVIR, VIDEX, SUSTIVA, INVIRASE, APTIVUS, NORVIR, KALETRA, PREZISTA, TRUVADA, KIVEXA, COMBIVIR, REYATAZ, VIRAMUNE, ZIAGEN, ZERIT, EMTRIVA, EPIVIR, VIREAD, RETROVIR, VIDEX, SUSTIVA, INVIRASE, APTIVUS, NORVIR
SIMIT sezione Regione Lombardia
chronic HIV infection
 
06/13
NCT00143702: D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)

Completed
2/3
80
Canada
d4T, Abacavir, Riboflavin and Thiamine (Supplementation)
University of British Columbia, GlaxoSmithKline, CIHR Canadian HIV Trials Network
Acidosis, Lactic
08/06
08/06

Download Options